August 30, 2014 10:13 AM ET

Biotechnology

Company Overview of Din Bostad Sverige AB, Prior to Reverse Merger with Din Bostad Riks AB

Company Overview

As of September 30, 2006, Din Bostad Sverige AB was acquired by Din Bostad Riks AB in a reverse merger transaction. Din Bostad AB is a biotechnology research company that engages in the development and commercialization of candidate drugs in Sweden. It develops alphaHGA, an HIV-inhibiting drug, which is in phase I/II trial; and RAS technology platform. The company’s ChronVac-C project develops a therapeutic vaccine for the treatment of chronic hepatitis C infections. It also focuses on the development of therapeutic and prophylactic vaccines against influenza A and HIV. The company was founded in 1997 as Tripep AB and changed its name to Din Bostad AB in October 2006. The company is based in...

Halsovagen 7

Hoddinge,  SE-14157

Sweden

Founded in 1997

Phone:

46 84 49 84 80

Key Executives for Din Bostad Sverige AB, Prior to Reverse Merger with Din Bostad Riks AB

Din Bostad Sverige AB, Prior to Reverse Merger with Din Bostad Riks AB does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Exocure Europe
Oncomed AB Europe
Fujirebio Diagnostics AB Europe
Eribis Pharmaceuticals AB Europe
Gnothis AB Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Din Bostad Sverige AB, Prior to Reverse Merger with Din Bostad Riks AB, please visit www.dinbostad.se. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.